Pursennid /00142207/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 23.0%
Blood Pressure Increased 13.1%
Hyperphosphataemia 13.1%
Productive Cough 9.8%
Constipation Prophylaxis 6.6%
Dysuria 6.6%
Hyperchlorhydria 6.6%
Insomnia 6.6%
Pruritus 6.6%
Hypertension 3.3%
Cardiac Failure 1.6%
Constipation 1.6%
Hyperuricaemia 1.6%
Wrong Technique In Drug Usage Process 50.0%
Malignant Tumour Excision 16.7%
Somnolence 16.7%
White Blood Cell Count Decreased 16.7%
Concomitant
Product Used For Unknown Indication 32.1%
Constipation 10.3%
Prophylaxis 9.5%
Hyperphosphataemia 7.4%
Multiple Myeloma 6.6%
Hypertension 4.8%
Cardiac Failure 4.5%
Cancer Pain 3.2%
Hyperparathyroidism Secondary 2.6%
Depression 2.5%
Type 2 Diabetes Mellitus 2.4%
Pain 2.2%
Renal Cell Carcinoma 2.0%
Chronic Hepatitis C 1.9%
Insomnia 1.7%
Hepatitis C 1.5%
Myocardial Infarction 1.3%
Back Pain 1.2%
Cardiac Amyloidosis 1.2%
Diabetes Mellitus 1.1%
White Blood Cell Count Decreased 11.9%
Diverticular Perforation 6.8%
Interstitial Lung Disease 6.8%
Suicide Attempt 6.8%
Wheezing 6.8%
Myocardial Infarction 5.1%
Nausea 5.1%
Rash 5.1%
Septic Shock 5.1%
Small Intestinal Perforation 5.1%
Vomiting 5.1%
Abdominal Distension 3.4%
Blood Pressure Decreased 3.4%
Cerebral Infarction 3.4%
Femoral Neck Fracture 3.4%
Gait Disturbance 3.4%
Hypocalcaemia 3.4%
Hypoglycaemia 3.4%
Ileus Paralytic 3.4%
Insomnia 3.4%

Drug Data